7 companies in OrbiMed Advisors's investment portfolio.
Back to OrbiMed Advisors profile“Healthcare-focused investment platform spanning all stages from seed through IPO in biotech, pharmaceuticals, and digital health.”
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers.
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California.
Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Genomic diagnostics company that develops molecular tests to help physicians make treatment decisions for patients with thyroid, lung, and breast diseases.
OrbiMed Advisors has built a portfolio of 7 companies across 2 sectors, including Biotech, DevTools.
The portfolio reflects investments across the IPO stage, showing OrbiMed Advisors's approach to supporting companies at a focused stage of development.
OrbiMed Advisors has invested in 7+ companies across 2 different sectors.
OrbiMed Advisors's portfolio spans Biotech, DevTools. This diversification reflects the firm's broad investment thesis and sector expertise.
OrbiMed Advisors invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.